Literature DB >> 16728931

Recurrent thrombotic thrombocytopenic purpura treated repeatedly and successfully with the monoclonal antibody rituximab.

Lavinia Herbei1, Parameswaran Venugopal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16728931

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  2 in total

1.  A dramatic response to rituximab in a patient with resistant thrombotic thrombocytopenic purpura (TTP) who developed acute stroke.

Authors:  Hakan Ozdogu; Can Boga; Ebru Kizilkilic; Mahmut Yeral; Ilknur Kozanoglu; Mehmet Karatas
Journal:  J Thromb Thrombolysis       Date:  2007-01-13       Impact factor: 2.300

Review 2.  Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2008-07-01       Impact factor: 22.113
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.